Trials / Completed
CompletedNCT00861445
A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy
A Randomized, Double-Blind Placebo Controlled Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose is to investigate the safety and efficacy of SPM927 in patients with Painful Diabetic Neuropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPM927/Lacosamide | SPM927 (film-coated tablets, 25/50/100mg per tablet), dosage 400mg/day, intake in the morning and in the evening, intake for 10 weeks |
| OTHER | Placebo | Placebo tablets two times a day for 10 weeks |
Timeline
- Start date
- 2001-06-01
- Primary completion
- 2003-01-01
- Completion
- 2003-02-01
- First posted
- 2009-03-13
- Last updated
- 2014-10-20
Source: ClinicalTrials.gov record NCT00861445. Inclusion in this directory is not an endorsement.